Information Provided By:
Fly News Breaks for January 12, 2016
HTWR
Jan 12, 2016 | 07:39 EDT
Canaccord said the weakness in HeartWare following its pre-announcement has provided a buying opportunity for investors looking for long-term growth from both its VAD franchise and Valtech franchise. Canaccord reiterated its Buy rating and $70 price target on HeartWare shares.
News For HTWR From the Last 2 Days
There are no results for your query HTWR